2Background: Whole genome sequencing (WGS) has been proposed as a tool for 3 diagnosing drug resistance in tuberculosis. However, reports of its effectiveness in endemic 4 countries with important numbers of drug resistance are scarce. The goal of this study was 5 to evaluate the effectiveness of this procedure in isolates from a tuberculosis endemic 6 region in Mexico. 7 Methods: WGS analysis was performed in 81 tuberculosis positive clinical isolates with a 8 known phenotypic profile of resistance against first-line drugs (isoniazid, rifampin, 9 ethambutol, pyrazinamide and streptomycin). Mutations related to drug resistance were 10 identified for each isolate; drug resistant genotypes were predicted and compared with the 11 phenotypic profile. Genotypes and transmission clusters based on genetic distances were 12 also characterized. 13 Findings:. Prediction by WGS analysis of resistance against isoniazid, rifampicin, 14ethambutol, pyrazinamide and streptomycin showed sensitivity values of 84%, 96%, 71%, 15 75% and 29%, while specificity values were 100%, 94%, 90%, 90% and 98%, respectively.
16Prediction of multidrug resistance showed a sensitivity of 89% and specificity of 97%. 17 Moreover, WGS analysis revealed polymorphisms related to second-line drug resistance, 18 enabling classification of eight and two clinical isolates as pre-and extreme drug-resistant 19 cases, respectively.20